NCCN updates COVID-19 guidelines for cancer patients

NCCN awards go to Green, Kumar, Black, and the COVID-19 Vaccination Advisory Committee

Darcie Green, Shaji K. Kumar, Donna Black, and the NCCN COVID-19 Vaccination Advisory Committee received of the 2024 National Comprehensive Cancer Network awards.

April 19, 2024

Vol.50 No.16

Drugs & Targets

MD Anderson and CureVac collaborate to develop mRNA cancer vaccines

MD Anderson Cancer Center and CureVac N.V. are entering a co-development and licensing agreement to develop novel mRNA-based cancer vaccines.

April 19, 2024

Vol.50 No.16

Clinical Roundup

Phase II study of personalized cancer vaccine in CRC shows positive preliminary PFS and long-term ctDNA data

The ongoing, signal-seeking phase II portion of the phase II/III study evaluating Granite, a personalized neoantigen cancer vaccine, in front-line metastatic microsatellite stable colorectal cancer, produced positive preliminary data.

April 05, 2024

Vol.50 No.14

In the Archives

Yale’s Richard Edelson on what got him started in research for cutaneous T-cell lymphoma

Richard Edelson began his career at NCI, where he was training to become a cancer immunologist.

October 27, 2023

Vol.49 No.40

Clinical Roundup

COVID-19 pandemic associated with decline in number of reported cancer cases

The COVID-19 pandemic was associated with significant changes in diagnoses of all cancer types in 2020, with a 14.4% overall decline in the number of reported cancer cases in cancer centers accredited by the Commission on Cancer (CoC) compared with the prior year.

October 27, 2023

Vol.49 No.40

Clinical Roundup

Longitudinal nucleocapsid antibody testing reveals undocumented SARS-CoV-2 infections in patients with lung cancer

A study demonstrated that viral immune evasion enabled breakthrough infections of COVID-19 in patients with lung cancer, highlighting the importance of effective monitoring mechanisms, such as anti-N serology, to track infection rates in specific vulnerable populations.

October 27, 2023

Vol.49 No.40

NCCN updates COVID-19 guidelines for cancer patients

YOU MAY BE INTERESTED IN

NCCN awards go to Green, Kumar, Black, and the COVID-19 Vaccination Advisory Committee

MD Anderson and CureVac collaborate to develop mRNA cancer vaccines

Phase II study of personalized cancer vaccine in CRC shows positive preliminary PFS and long-term ctDNA data

Yale’s Richard Edelson on what got him started in research for cutaneous T-cell lymphoma

COVID-19 pandemic associated with decline in number of reported cancer cases

Longitudinal nucleocapsid antibody testing reveals undocumented SARS-CoV-2 infections in patients with lung cancer

Renew today!

Subscriber content

Login